Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02194868
What this trial is testing

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Assistance Publique - Hôpitaux de Paris 57
Not applicableUnknownNCT03994497
What this trial is testing

Evaluation of the Level of Expression of CD45RC on T Lymphocytes as a Predictive Biomarker of Acute Rejection After Renal Transplantation

Who this might be right for
End-stage Renal Disease
University Hospital, Angers 150
Large-scale testing (Phase 3)Study completedNCT00678275
What this trial is testing

Chronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Universitätsklinikum Hamburg-Eppendorf 161
Testing effectiveness (Phase 2)Study completedNCT00393029
What this trial is testing

Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes

Who this might be right for
Anti-p53 TCR-Gene
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT00179075
What this trial is testing

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell TransplantationGraft vs Host Disease
Vanderbilt University 100
Early research (Phase 1)UnknownNCT02779439
What this trial is testing

Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation

Who this might be right for
CMV InfectionEBVAdenovirus
University of Sydney 25
Not applicableStudy completedNCT03736044
What this trial is testing

Reconstitution of CD4+CD25highCD127low/-Tcell

Who this might be right for
Rheumatoid Arthritis
University Hospital of Ferrara 48
Not applicableUnknownNCT05084807
What this trial is testing

Evaluation of the Lymphocyte Subpopulations in the Normal Mucosa of the Upper Digestive Tract

Who this might be right for
Lymphocytic Enteritis (Disorder)Healthy Volunteers
Hospital Mutua de Terrassa 20
Early research (Phase 1)Temporarily pausedNCT06792344
What this trial is testing

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)
The Children's Hospital of Zhejiang University School of Medicine 12
Post-approval studies (Phase 4)WithdrawnNCT04770701
What this trial is testing

Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes

Who this might be right for
HIV-1-infectionAIDS
Trieu, Nguyen Thi, M.D.
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Not applicableUnknownNCT05099458
What this trial is testing

T-cell Dysfunction in Chronic HBV Infection

Who this might be right for
Chronic Hepatitis B Virus
University Hospital, Strasbourg, France 50
Testing effectiveness (Phase 2)Study completedNCT06390748
What this trial is testing

Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes

Who this might be right for
SepsisLymphocyte Disorder TImmunologic Paralysis+4 more
Lin Chen 150
Early research (Phase 1)Ended earlyNCT01551043
What this trial is testing

Allo CART-19 Protocol

Who this might be right for
Acute Lymphocytic Leukemia
University of Pennsylvania 2
Testing effectiveness (Phase 2)Study completedNCT03744676
What this trial is testing

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphoma, B-Cell+7 more
Juno Therapeutics, a Subsidiary of Celgene 104
Early research (Phase 1)Not Yet RecruitingNCT05582590
What this trial is testing

Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers

Who this might be right for
Oropharyngeal CancerHuman Papilloma VirusHead and Neck Cancer+8 more
NexImmune Inc. 36
Early research (Phase 1)Ended earlyNCT05350163
What this trial is testing

T-cell Receptor α/β Depleted Donor Lymphocyte Infusion

Who this might be right for
Lymphoid Leukemia, AcuteMyeloid MalignancyPlasma Cell Tumor
Guenther Koehne 11
Early research (Phase 1)Looking for participantsNCT02870244
What this trial is testing

Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Who this might be right for
Melanoma
Loyola University 18
Testing effectiveness (Phase 2)Study completedNCT00506129
What this trial is testing

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
LymphomaDisorder Related to Bone Marrow Transplantation
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Ended earlyNCT02459067
What this trial is testing

ImmuniCell® in Patients With Advanced Cancers

Who this might be right for
Malignant MelanomaNon-small Cell Lung CancerRenal Cell Cancer
TC Biopharm 8
Next Page